Question 1

Where can I buy Levetiracetam?

Accepted Answer

Levetiracetam can be procured through GNH Pharmaceuticals USA LLC (https://gnh-usa.com/), a specialist in orphan drug supply and named patient programs. Visit https://gnh-usa.com/ or contact them directly for availability and pricing.

Question 2

How can I access Levetiracetam in my country?

Accepted Answer

Levetiracetam is available in 11 countries through named patient programs, compassionate use, and other regulatory pathways. Contact GNH Pharmaceuticals USA LLC at https://gnh-usa.com/ for country-specific access guidance.

Question 3

What conditions does Levetiracetam treat?

Accepted Answer

Levetiracetam is indicated for: partial monosomy of the short arm of chromosome 20, partial duplication of chromosome 10, Xia-Gibbs Syndrome, benign familial neonatal epilepsy, benign adult familial myoclonic epilepsy, syndrome with corpus callosum agenesis /dysgenesis as a major feature, syndromic neurometabolic disease with non-X-linked intellectual disability, myoclonus, familial temporal lobe epilepsy 3, subependymal nodular heterotopia, generalized epilepsy with febrile seizures plus, rare genetic disease with myoclonus as a major feature, early infantile epileptic encephalopathy 23. Partial-onset seizures, myoclonic seizures, primary generalized tonic-clonic seizures, epilepsy associated with structural brain malformations

Country	Access Route	Regulatory Pathway	Lead Time	Status
Australia	—	—	—	—
Brazil	—	—	—	—
Canada	—	—	—	—
Germany	—	—	—	—
Spain	—	—	—	—
France	—	—	—	—
United Kingdom	—	—	—	—
India	—	—	—	—
Italy	—	—	—	—
Japan	—	—	—	—
United States	—	—	—	—

Generic Name	Levetiracetam
Brands	1 brand available
Active Ingredient	Levetiracetam
Drug Class	Partial-onset seizures
Manufacturer	UCB Pharma
Dosage Forms	Oral tablet 250mg, 500mg, 750mg, 1000mg; Oral solution 100mg/mL; IV infusion 500mg/5mL
Medical Code	`N03AX14`
Orphan Status	No
Cold Chain	Not Required
Lead Time	3 days
Reg. Status	FDA Approved, EMA Approved
Clinical Trial	NCT00150449
Countries	11 countries

Levetiracetam

Description

Indications & Therapeutic Use

Global Availability (11 countries)

Available Through